Abstract

We comment on a unique country-wide scale field evaluation of rapid diagnostic test (RDT) for meningococcal meningitis in Niger. The authors reported the good sensitivity and specificity of the test, and the reliability of results obtained in the field by non-specialized health staff. This finding allows us to consider RDT as a good candidate laboratory tool to be used for the case-based surveillance system, post introduction of the new conjugate A vaccine (MenAfriVac) in the African meningitis belt countries. In addition, RDT is also a potential point of care test to improve the management of meningitis patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.